NasdaqGS - Nasdaq Real Time Price • USD
Atea Pharmaceuticals, Inc. (AVIR)
As of 12:29 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.61 | -0.68 | -2.76 | -2.92 |
| Low Estimate | -0.63 | -0.75 | -3.03 | -3.14 |
| High Estimate | -0.57 | -0.62 | -2.5 | -2.5 |
| Year Ago EPS | -0.43 | -0.34 | -1.63 | -2.76 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | 54.12M |
| Low Estimate | -- | -- | -- | 38M |
| High Estimate | -- | -- | -- | 76.47M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.48 | -0.47 | -0.48 | -0.5 |
| EPS Actual | -0.43 | -0.34 | -0.4 | -0.47 |
| Difference | 0.05 | 0.13 | 0.08 | 0.03 |
| Surprise % | 10.40% | 27.70% | 16.70% | 6.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.61 | -0.68 | -2.76 | -2.92 |
| 7 Days Ago | -0.61 | -0.68 | -2.76 | -2.92 |
| 30 Days Ago | -0.61 | -0.68 | -2.76 | -2.92 |
| 60 Days Ago | -0.61 | -0.68 | -2.76 | -2.92 |
| 90 Days Ago | -0.61 | -0.64 | -2.82 | 0.1 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | AVIR | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -41.90% | -- | -- | 8.50% |
| Next Qtr. | -100.00% | -- | -- | 11.70% |
| Current Year | -69.30% | -- | -- | 5.60% |
| Next Year | -5.80% | -- | -- | 13.20% |
| Next 5 Years (per annum) | -- | -- | -- | 11.07% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Downgrade | JP Morgan: Neutral to Underweight | 8/10/2023 |
| Maintains | JP Morgan: Neutral | 3/16/2023 |
| Maintains | SVB Leerink: Market Perform | 1/27/2023 |
| Maintains | Morgan Stanley: Underweight | 1/24/2023 |
| Maintains | Morgan Stanley: Underweight | 8/15/2022 |
| Maintains | JP Morgan: Neutral | 3/2/2022 |
Related Tickers
TIL Instil Bio, Inc.
11.51
+2.22%
ACHL Achilles Therapeutics plc
0.9000
-2.06%
RPHM Reneo Pharmaceuticals, Inc.
1.8600
+1.64%
ASMB Assembly Biosciences, Inc.
13.00
+0.39%
SPRO Spero Therapeutics, Inc.
1.6900
+1.20%
TBPH Theravance Biopharma, Inc.
9.49
0.00%
NXTC NextCure, Inc.
1.6700
+5.73%
ALGS Aligos Therapeutics, Inc.
0.7700
-1.69%
GLPG Galapagos NV
28.89
-0.48%
GLPG.AS Galapagos NV
26.82
-0.74%